Increasing demand for precise drug delivery systems, growing need to directly administer chemotherapy drugs into bloodstream, and technological advancements in infusion pumps are some key factors expected to drive market growth
According to Emergen Research, the global drug infusion market size was USD 10.56 billion in 2020 and is expected to reach USD 18.17 billion in 2028 and register a revenue CAGR of 7.1% during the forecast period, 2021-2028.
Drug infusion systems are used to ensure accurate administration of drugs such as medications or chemotherapy drugs for intravenous therapy. Infusion therapy has emerged as a robust drug system over the recent past owing to its ability to continuously and directly administer medication into the circulation system of patients. Infusion devices can be implantable or wearable and are used for a wide range of applications such as chronic pain management, chemotherapy, or treatment of infectious diseases. Increasing need to administer accurate dosage of drugs, rising focus on patient safety, and growing prevalence of chronic diseases that require intravenous therapy are key factors expected to drive market revenue growth over the forecast period.
Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/692
Infusion therapy enables delivery of chemotherapy, anti-nausea, and other medications directly into bloodstream and is a viable alternative when there’s no efficient oral therapy available. Infusion therapy can be used for the treatment of autoimmune disorders, congestive heart failure, dehydration, pain, and immune deficiencies, among others. To ensure patient receives the correct dose of a drug, appropriate infusion device must be chosen for the drug. Modern drug infusion systems are equipped with reservoir, tubing, propulsion mechanism, flow catheter, and IV catheter. Drug infusions generally end in an IV catheter that is designed for insertion into a peripheral or central vein. Most infusion systems have built-in ports to merge other drug flows or inert crystalloids in a common fluid stream. Development of smart infusion pumps have led to their increased adoption in perioperative settings due to their numerous advantages such as enhanced capability to deliver small amounts of drugs at precisely programmed rates, identification of medications using bar codes, and seamless integration with electronic medical records or anesthesia information systems. These key factors are expected to further contribute to revenue growth of the drug infusion systems market.
Majority patients considered for drug infusion have been treated with other medications and therapies that have not been effective or led to complications or side effects. Patients suffering with chronic and severe pain that cannot be managed by oral or transdermal medications due to rising incidence of complications and off-target effects are treated with drug infusion therapy and this is another key factor expected to further boost adoption of drug infusion systems in healthcare settings. However, lack of knowledge regarding efficient working of infusion devices, medication errors associated with use of these devices, and accidental delivery of dead volume of drugs from the infusion systems and subsequent risks to patients are some key factors that can restrain market growth to a significant extent over the forecast period.
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Check Our Prices@ https://www.emergenresearch.com/select-license/692
Closed-loop System Segment to Dominate in Terms of Revenue Share:
Closed-loop system segment is expected to dominate other control systems segment in terms of revenue share over the forecast period attributable to increasing use of closed-loop systems to improve positional accuracy of infusion devices, enhance patient safety, and to automate hemodynamic resuscitation in septic shock patients.
Continuous Infusion Segment to Account for Largest Revenue Share:
Continuous infusion segment to account for largest revenue share in the global market over the forecast period owing to rising application of continuous infusion to ensure a controlled and precise dose delivery of medications, fluids, nutrients, and therapeutics.
Intravenous Segment to Register Robust Revenue Growth:
Intravenous segment is expected to register robust revenue growth over the forecast period attributable to increasing use of intravenous route for delivery of insulin in diabetic patients, precise delivery of drugs and other medication for their effective functioning, and treat serious and chronic infections that do not respond to oral antibiotics.
Asia Pacific to Register Fastest Revenue CAGR:
Asia Pacific market revenue is expected to register robust revenue CAGR over the forecast period owing to rising prevalence of cancer, diabetes, and chronic infections, increasing investment to develop state-of-the-art healthcare facilities and advanced medical devices, strategic collaborations between key companies to launch advanced medical equipment, rising awareness regarding drug infusion therapy, and rapid adoption of advanced medical devices in the region.
Major Companies in the Market Include:
- Medtronic Plc.
- Arcomed Ag
- Baxter International Inc.
- Insulet Corporation
- Smiths Group Plc.
- Becton, Dickinson and Company
- Halyard Health, Inc.
- ICU Medical, Inc.
- Flowonix Medical Inc.
- Zyno Medical LLC
For the purpose of this report, Emergen Research has segmented the global drug infusion systems market on the basis of control systems, infusion type, administration route, application, end-use, and region:
Control Systems Outlook (Revenue, USD Billion; 2018–2028)
- Open Loop System
- Closed Loop System
Infusion Type Outlook (Revenue, USD Billion; 2018–2028)
- Continuous Infusion
- Intermittent Infusion
- Patient Controlled Infusion
- Total Parenteral Nutrition
Administration Route Outlook (Revenue, USD Billion; 2018–2028)
Application Outlook (Revenue, USD Billion; 2018–2028)
End-Use Outlook (Revenue, USD Billion; 2018–2028)
- Diagnostic Centers
- Ambulatory Surgical Centers
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/drug-infusion-systems-market
Regional Outlook (Revenue, USD Billion; 2018–2028)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
Take a Look at our Related Reports:
Alopecia Market By Type, By Application, By End-Users, By Distribution Channel, Forecasts to 2027
Cerebrospinal Fluid Management Market By Product (Critical Care Product, Shunts & Valves, Others), By Patient Type (Geriatric, Adult, Pediatric), By End-Use (Clinics, Hospitals, Ambulatory Surgical Centers, Others), By Region Forecasts to 2027
Diabetic Care Market By Devices (Monitoring Devices, Insulin Pumps, Syringes and Cartridges, Disposable Pens, Jet Injectors), By Distribution Channel (Hospital, Retail and Online Pharmacies, Diabetic Clinics, Others), By End User (Hospitals, Homecare, Diagnostic Centers) and By Regions Forecasts to 2027
Brachytherapy Market By Type, By Application, By End-Users, Forecasts to 2027
Inhalation and Nasal Spray Market By Application (Asthma, COPD, Allergic Rhinitis, Others), By Drug Type (Corticosteroids, Bronchodilators, Antihistamines, Decongestant Sprays, Others) and By Regions Forecasts to 2027
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
Read Full Press Release: https://www.emergenresearch.com/press-release/global-drug-infusion-systems-market